1-4 of 4
Moh-Lim Ong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Effectiveness of Ravulizumab Among Adults with Atypical Hemolytic Uremic Syndrome (aHUS) Who Switched to Ravulizumab within 3 Months of Eculizumab Treatment: A Physician Panel-Based Chart Review Study (aHUS IMPACT)

Shruti Chaturvedi, Yan Wang, Moh-Lim Ong, Arpita Nag, Rui Song, Lynn Huynh, Jordan A. Burdeau, Mei Sheng Duh, Ramy Magdy Hanna
Journal: Blood
Blood (2024) 144 (Supplement 1): 2613.
https://doi.org/10.1182/blood-2024-194225
Published: 2024
Journal Articles

Patient Characteristics and Diagnostic Journey of Thrombotic Microangiopathy Associated with a Trigger: A Real-World, Retrospective, Multi-National Study

Yan Wang, Francesca Gatta, Joseph Conyers, Gregor Gibson, Kieran Wynne-Cattanach, Karl-Johan Myrén, Moh-Lim Ong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5526.
https://doi.org/10.1182/blood-2023-179231
Published: 2023
Journal Articles

Real-World Analysis of the Underdiagnosis, Clinical Outcomes and Associated Burden of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA) in the United States of America

Yan Wang, Andrew Rava, Marlene Smuzynski, Bonny Shah, Anusorn Thanataveerat, Imad Al Dakkak, Moh-Lim Ong, Christopher C Dvorak, Vincent Ho
Journal: Blood
Blood (2023) 142 (Supplement 1): 491.
https://doi.org/10.1182/blood-2023-177671
Published: 2023
Journal Articles

Real-World Patient Characteristics, Treatment Patterns and Outcomes for Patients with Atypical Hemolytic Uremic Syndrome Who Have Switched from Eculizumab to Ravulizumab in the USA

Yan Wang, Imad Al-Dakkak, Katherine Garlo, Moh-Lim Ong, Ioannis Tomazos, Arash Mahajerin
Journal: Blood
Blood (2021) 138 (Supplement 1): 5003.
https://doi.org/10.1182/blood-2021-152598
Published: 2021